Bradley Gray
Family Medicine · Florence, KYNPI 1073752010
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $40,619 of the $50,542 with a category attached, or 80.4%. AbbVie accounts for 77.5% of it on its own, with 40 other manufacturers making up the rest. 2025 is the largest year on record at $28,409, more than ten times the $2,274 reported in 2019. Among family medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 529 payments — averaging $95.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$39K
- Pfizer$5K
- AstraZeneca$878
- Novo Nordisk$678
- Lilly USA, LLC$604
- GSK$363
- plus $3K from 35 others
What the payments were for
- Speaking & faculty fees$40,61980%
- Travel & lodging$8852%
- Food & beverage$8,93718%
- Education$1020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$50,542 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 99 | $144,767 |
| JardianceEmpagliflozin | 66 | $86,951 |
| EliquisApixaban | 36 | $36,681 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 31 | $32,330 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $25,740 |
| OzempicSemaglutide | 19 | $22,974 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $22,835 |
| FarxigaDapagliflozin Propanediol | 21 | $21,952 |
| RexultiBrexpiprazole | 13 | $18,147 |
| TrulicityDulaglutide | 17 | $15,536 |
| Tresiba Flextouch U-100Insulin Degludec | 25 | $15,064 |
| GemtesaVibegron | 12 | $12,355 |
| EntrestoSacubitril/Valsartan | 17 | $11,199 |
| Droxidopa | 12 | $4,757 |
| Rosuvastatin Calcium | 345 | $3,751 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $604 | $160,302116 claims |
| Boehringer IngelheimJardiance | $226 | $86,95166 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $878 | $54,28252 claims |
| PfizerEliquis | $5,479 | $36,68136 claims |
| GSKTrelegy Ellipta | $363 | $25,74023 claims |
| Novo NordiskOzempic | $678 | $22,97419 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $161 | $18,14713 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $65 | $12,35512 claims |
| NovartisEntresto | $220 | $11,19917 claims |
| AbbVieSynthroid | $39,194 | $1,81430 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Florence
- Edward SchumannFlorence$79K
- Matthew BarthFlorence$14K
- Gregory MullenFlorence$10K
- Christopher RhyneLouisville$933K
- John RichardLexington$226K
- James TurnboPaducah$124K
- Ronald KoffNew Castle$71K
- Suraj GathaniLouisville$69K
- Jackie KazeeAshland$45K
- Mandy WhittLouisville$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.